middle.news
BLS starts FY27 with record revenue and Scotland facility ready for inspection
8:28am on Thursday 15th of October, 2026 AEDT
•
Pharmaceuticals
Read Story
BLS starts FY27 with record revenue and Scotland facility ready for inspection
8:28am on Thursday 15th of October, 2026 AEDT
Key Points
Record Q1 FY27 revenue reported at either $26.7 million or $27.5 million
$2.0 million positive operating cash flow and $12.7 million closing cash
FY27 guidance reaffirmed at $105 million to $115 million revenue
Scotland GMP facility ready for inspection and licensing, subject to approvals
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Bls Pharmaceuticals (ASX:BLS)
OPEN ARTICLE